CD8A and neoplasm: Interestingly, PeptiCRAd1 showed higher CD8+/CD4+ T-cell ratio (Figure 8A) within the TME of the treated tumor (right side) well in line with an increased CD8+ T-cell infiltration (Figure 8B) in both treated (right side) and untreated (left side) cancer lesions.